Clay B Siegall, Seattle Genetics's President and CEO and a director of the company, recently cashed-in 800 options. The options were exercised at $10.20, while the disposals took place at $40.00 per share, on April 25, 2016. Siegall continues to hold 584,060 shares of the company. Siegall operates out of Bothell, WA. Some additional info was provided as follows:
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Shares vested at a rate of 25% on 5/25/08 and monthly thereafter until all the shares were fully vested on 5/25/11.
The above information was disclosed in a filing to th e SEC. To see the filing, click .
To receive a free e-mail notification whenever Seattle Genetics makes a similar move,
Other recent filings from the company include the following:
- April 7, 2016
- April 6, 2016